Botanical species · safety record

Smilax glabra

The EFSA Compendium of Botanicals holds 4 constituent measurements for Smilax glabra. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Smilax glabra Roxb.

4Constituent measurements
0Safety records
3Cited sources
96Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 96 licensed products naming Smilax glabra as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Dried rhizome
  • Rhizome
  • Rhizome(s)
  • Root
  • Root and rhizome

What the records describe

Constituents measured

  • Isoflavones1
  • Lignans1
  • Phenylpropanoids1
  • Syringaresinol1

Plant parts

  • Roots and other underground parts4

Preparations

  • Solvent extraction4

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
IsoflavonesRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LignansRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
PhenylpropanoidsRoots and other underground partsSolvent extractionUHPLC-MS-MSNo resolvable identifier
SyringaresinolRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Chen, Shao-Dan., Lu, Chuan-Jian., Zhao, Rui-Zhi. Qualitative and quantitative analysis of Rhizoma Smilacis glabrae by ultra high performance liquid chromatography coupled with LTQ OrbitrapXL hybrid mass spectrometry. Molecules, 2014, p. 10427-10439.
  2. Yi, YJ., Cao, ZZ., Yang, DL., Cao, YA., Wu, YP., Zhao, SX. A new isoflavone from Smilax glabra. Molecules, 1998, vol. 3, no. 5, p. 145-147. DOI
  3. Lu Chuan-Li., Zhu Wei., Wang Dong-Mei., Xu Xiao-Jie., Lu Chuan-Jian., Chen Wen-Long., Hu Meng-Mei., Wang Min. Inhibitory Effects of Chemical Compounds Isolated from the Rhizome of Smilax glabra on Nitric Oxide and Tumor Necrosis Factor- alpha Production in Lipopolysaccharide-Induced RAW264.7 Cell. Evidence-based complementary and alternative medicine : ecam, 2015.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue